| Literature DB >> 35831805 |
Yili Chen1, Yao Chen1, Pingjuan Liu1, Penghao Guo1, Zhongwen Wu1, Yaqin Peng1, Jiankai Deng1, Yannan Kong2, Yingpeng Cui1, Kang Liao3, Bin Huang4.
Abstract
BACKGROUND: Bloodstream infection (BSI) caused by carbapenem resistant Klebsiella pneumoniae (CRKP), especially in elderly patients, results in higher morbidity and mortality. The purpose of this study was to assess risk factors associated with CRKP BSI and short-term mortality among elderly patients in China.Entities:
Keywords: Bloodstream infection; Carbapenem-resistant K. pneumoniae; Elderly patients; Mortality; Risk factor
Mesh:
Substances:
Year: 2022 PMID: 35831805 PMCID: PMC9281020 DOI: 10.1186/s12877-022-03275-1
Source DB: PubMed Journal: BMC Geriatr ISSN: 1471-2318 Impact factor: 4.070
Characteristic of patients, univariate and multi-variate analysis of risk factors for BSI caused by CRKP compared with patients with BSI caused by CSKP
| Total ( | CSKP ( | CRKP ( | OR | |||
|---|---|---|---|---|---|---|
| Demographic variables | ||||||
| Male sex | 166(65.9) | 143(64.1) | 23(79.3) | 0.105 | ||
| Age | ||||||
| 60–70 | 138(54.8) | 123(55.2) | 15(51.7) | 0.78 | ||
| 70–80 | 73(29.0) | 65(29.2) | 6(20.7) | 0.66 | ||
| 80–90 | 38(15.1) | 33(14.8) | 5(17.2) | 0.44 | ||
| > 90 | 5(2.0) | 2(0.9) | 3(10.3) | 0.26 | ||
| Co-morbidities | ||||||
| Hypertension | 102(40.5) | 79(35.4) | 23(79.3) | < 0.001 | 13.789(3.883–48.969) | < 0.001 |
| Diabetes mellitus | 68(27.0) | 57(25.6) | 11(37.9) | 0.158 | ||
| Hematological tumors | 13(5.2) | 12(5.4) | 1(3.5) | 0.658 | ||
| Solid organ tumors | 94(37.3) | 86(38.6) | 8(27.6) | 0.25 | ||
| Previous bacterial infections | 102(40.5) | 85(38.1) | 17(58.6) | 0.034 | ||
| Septic Shock | 37(14.7) | 31(13.9) | 6(20.7) | 0.331 | ||
| Immunosuppression | 7(2.8) | 5(2.2) | 2(6.9) | 0.151 | ||
| Organ dysfunction | 62(24.6) | 54(24.2) | 8(27.6) | 0.692 | ||
| Antibiotics before KPN isolation | ||||||
| β-Lactam/lactamase combinations | 29(11.5) | 21(9.4) | 8(27.6) | 0.009 | ||
| cephalosporins | 47(18.6) | 35(15.7) | 12(41.4) | 0.001 | ||
| carbapenems | 45(17.9) | 28(12.6) | 17(58.6) | < 0.001 | 8.073(2.066–31.537) | 0.003 |
| quinolones | 23(9.1) | 19(8.5) | 4(13.8) | 0.354 | ||
| Hospital stays before onset | 6(2,13) | 5(1,12) | 16(5,33) | 0.016 | ||
| ICU stay | 59(23.4) | 38(17.0) | 21(72.4) | < 0.001 | 11.180(2.663–46.933) | 0.001 |
| Pathogen isolated from other sites | 96(38.1) | 75(33.6) | 21(72.4) | < 0.001 | ||
| Ward | ||||||
| Internal medicine | 128(50.8) | 123(55.2) | 5(17.2) | 0.98 | ||
| Surgical | 76(30.2) | 73(32.7) | 3(10.3) | 0.98 | ||
| ICU | 48(19.1) | 27(12.1) | 21(72.4) | < 0.001 | ||
| Invasive operation | ||||||
| Surgery | 68(27.0) | 61(27.3) | 7(24.1) | 0.714 | ||
| Puncture | 108(42.9) | 90(40.4) | 18(62.1) | 0.026 | ||
| Catheter | 28(11.1) | 22(9.9) | 6(20.7) | 0.081 | ||
| Mechanical ventilation | 31(12.3) | 18(8.1) | 13(44.8) | < 0.001 | ||
| Mortality | 27(10.7) | 13(5.8) | 14(48.3) | < 0.001 | ||
Data are expressed as n(%) or median(IQR)
Univariate and multi-variate analysis of risk factors for 28-day mortality in patients with KP BSI
| Survival ( | Death ( | OR | OR | |||
|---|---|---|---|---|---|---|
| Demographic variables | ||||||
| Male sex | 145(64.4) | 21(77.8) | 0.167 | |||
| Age | 69(64,76) | 70(64,79) | 0.134 | |||
| Carbapenem resistance | 15(6.7) | 14(51.9) | 15.077(6.015–37.789) | < 0.001 | 2.881((1.228–6.756) | 0.015 |
| Co-morbidities | ||||||
| Hypertension | 87(38.7) | 15(55.6) | 0.091 | |||
| Diabetes mellitus | 61(27.1) | 7(25.9) | 0.896 | |||
| Hematological tumors | 12(5.3) | 1(3.7) | 0.718 | |||
| Solid organ tumors | 85(37.8) | 9(33.3) | 0.652 | |||
| Infection(any) | 85(37.8) | 17(63.0) | 2.8(1.225–6.397) | 0.012 | 0.331 | |
| Septic Shock | 27(12.0) | 10(37.0) | 4.314(1.792–10.385) | 0.001 | 0.148 | |
| Immunosuppression | 5(2.2) | 2(7.4) | 0.121 | |||
| Organ dysfunction | 52(23.1) | 10(37.0) | 0.112 | |||
| Hospital stays before onset | 5(1,12) | 14(7,38) | 1.023(1.009–1.036) | 0.001 | 0.223 | |
| ICU stays before onset | 0(0,1) | 10(1,34) | 1.038(1.018–1.059) | < 0.001 | 0.613 | |
| Pathogen isolated from other sites | 75(33.3) | 21(77.8) | 7.000(2.711–18.076) | < 0.001 | 0.324 | |
| KP isolated in ICU | 27(12.0) | 21(77.8) | 25.667(9.514–69.241) | < 0.001 | 11.731(4.226–32.563) | < 0.001 |
| Invasive operation | ||||||
| surgery | 60(26.7) | 8(29.6) | 0.743 | |||
| puncture | 23(10.2) | 5(18.5) | 0.195 | |||
| catheter | 87(38.7) | 21(77.8) | 5.552(2.155–14.300) | < 0.001 | 0.060 | |
| Mechanical ventilation | 17(7.6) | 14(51.9) | 13.176(5.344–32.487) | < 0.001 | 0.327 | |
| Appropriate empirical therapy | 23(10.22) | 1(3.7) | 0.299 | |||
Data are expressed as n (%) or median (IQR)
Fig. 1Kaplan–Meier curves of elderly patients in ICU (green line) and non-ICU (blue line)
Fig. 2Kaplan–Meier analysis of elderly patients with CSKP-BSI and CRKP-BSI in ICU
Characteristics of patients with KP BSI in ICU
| Total ( | MICU ( | SICU ( | ||
|---|---|---|---|---|
| Demographic variables | ||||
| Male sex | 34(70.8) | 18(66.7) | 16(76.2) | 0.471 |
| Age | 69(65–77) | 69(65–77) | 69(69–75) | 0.834 |
| Length of ICU stay | 14(1,33) | 5(1,31) | 16(8,33) | 0.184 |
| Pathogen isolated from other parts | 38(79.2) | 24(88.9) | 14(66.7) | 0.06 |
| surgery | 13(27.1) | 2(7.4) | 11(52.4) | 0.001 |
| Carbapenem resistance | 21(43.6) | 15(55.6) | 6(28.6) | 0.062 |
| Mortality | 21(43.6) | 15(55.6) | 6(28.6) | 0.062 |
Data are expressed as n(%) or median(IQR)